| 청구기호 |
RA440.87.U6 A84 2013 |
| 형태사항 |
xiii, 290 p. ; 25 cm.
|
| 언어 |
English |
| 서지주기 |
Includes bibliographical references and index.
|
| 내용 |
The generation of evidence in medicine : evaluating the benefits and harms of treatment -- The use of evidence : federal regulation of prescription drugs and medical devices -- The subversion of evidence : the Rosiglitazone story -- Operate first, evidence later : the special case of surgery -- Doctors and evidence : evidence-based medicine -- Comparative effective research : a new "silver bullet" for U.S. health care costs -- The legislative odyssey of comparative effectiveness research : birth in 2002 to the first federal mandate in 2003 -- 2005 to 2007 : the health services research community stirs, the "B" word awakens policymakers, and the House CHAMP Act creates divisions -- 2008 to 2010 : the Baucus-Conrad bills, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act -- The scope, financing, and processes of federally-mandated comparative effectiveness research and why they matter -- Aligning clinical practice with best evidence of comparative effectiveness : payment policy for evidence-based medical care -- Dealing with uncertainty : payment policy for the generation of evidence as part of clinical practice.
|
| 주제 |
Medical care --Research --United States --Evaluation.
Evidence-based medicine --United States.
Medical care, Cost of --Law and legislation --United States.
Medical policy --United States.
Comparative Effectiveness Research --history --United States.
Health Care Costs --legislation ＆ jurisprudence --United States.
Comparative Effectiveness Research --legislation ＆ jurisprudence --United States.
Evidence-Based Medicine --United States.
Government Regulation --United States.
History, 21st Century --United States.
|
| LCCN |
2013006780
|
| ISBN |
9780199968565 (hardback : alk. paper)
, 019996856X (hardback : alk. paper)
, 9780199969579 (e-book)
, 0199969574 (e-book)
|
| QR CODE |
|
